Table 1.
Baseline characteristics of participants.
| Characteristic mean (SD) or % |
Exercise (n = 35) |
Usual care (n = 30) |
Nonadherers (n = 15) |
Adherers (n = 20) |
|---|---|---|---|---|
| Age (yr) | 56.5 (9.8) | 55.1 (7.6) | 57.5 (12.8) | 55.7 (6.9) |
| Weight (kg) | 82.1 (16.5) | 77.2 (20.4) | 86.6 (17.0) | 78.7 (15.6) |
| Height (cm) | 161.8 (6.2) | 163.2 (6.5) | 161.3 (5.6) | 164.6 (6.7) |
| BMI (kg/m2) | 30.8 (5.9) | 29.4 (7.4) | 33.1 (4.8) | 29.1 (6.1) |
| Ethnicity (%) | ||||
| White | 83% | 90% | 90% | 85% |
| African-American | 17% | 7% | 20% | 15% |
| Asian/Pacific Islander | 0% | 3% | 0% | 0% |
| Education (%) | ||||
| High school graduate | 43% | 50% | 30% | 60% |
| College graduate | 57% | 50% | 70% | 40% |
| Time since diagnosis (y) | 3.6 (2.2) | 3.3 (2.6) | 3.5 (2.3) | 3.5 (2.1) |
| Disease stage (%) | ||||
| In Situ | 11% | 10% | 13% | 10% |
| Stage I | 54% | 27% | 67% | 45% |
| Stage II | 26% | 47% | 13% | 35% |
| Stage IIIA | 9% | 17% | 7% | 10% |
| Treatment (%) | ||||
| None | 6% | 13% | 13% | 0% |
| Radiation only | 43% | 23% | 47% | 40% |
| Any chemotherapy | 51% | 63% | 40% | 60% |
| Hormone therapy (%) | ||||
| None | 43% | 30% | 33% | 50% |
| Tamoxifen | 29% | 23% | 33% | 25% |
| Aromatase inhibitors | 29% | 47% | 33% | 25% |
| Physical activity questionnaire (min per week of moderate to vigorous intensity recreational activity) | 13.0 (24.0) | 12.0 (20.0) | 5.7 (10.2) | 19.4 (29.6) |
Note. No statistically significant differences between exercise, usual care groups, and exercise adherers versus nonadherers at baseline were observed.